Inspira Technologies Oxy B.H.N. Ltd (IINN)

2026-05-18T11:49:41.000Z - 16 hours ago

Inspira Technologies gets $580,000 purchase order from NYU Langone for ART100

May 18, 2026, 7:30 AM EDT - 16 hours ago

NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

2026-05-11T16:55:56.000Z - 7 days ago

Inspira Technologies CEO issues letter to shareholders on strategic direction

May 11, 2026, 7:31 AM EDT - 7 days ago

Inspira Technologies CEO Issues Letter to Shareholders on Strategic Direction and Value Creation Plan

2026-05-01T13:20:48.000Z - 17 days ago

Inspira Technologies secures $596,000 purchase order from Irish university

May 1, 2026, 8:21 AM EDT - 17 days ago

Inspira Secures $596,000 AME System Order from Leading Irish Technological University

2026-04-30T14:03:27.000Z - 18 days ago

Inspira Technologies enters joint development agreement with Qarakal Quantum

Apr 30, 2026, 8:01 AM EDT - 18 days ago

Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems

2026-04-28T14:11:27.000Z - 20 days ago

Inspira Technologies receives $390,000 payment, recurring revenue stream

Apr 28, 2026, 8:51 AM EDT - 20 days ago

Inspira Technologies Secures Fully Paid $390,000 Purchase Order and Recurring Revenue Stream from Premier APAC University

2026-04-16T15:18:27.000Z - 4 weeks ago

Inspira Technologies completes commercial deployment of AME System

Apr 16, 2026, 9:21 AM EDT - 4 weeks ago

Inspira Completes Commercial Deployment of its AME System at a Tier-1 U.S. Defense Entity

2026-04-14T12:47:24.000Z - 4 weeks ago

Inspira Technologies appoints Yoav Rozanovich as chief business officer

Apr 14, 2026, 8:01 AM EDT - 4 weeks ago

Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion

NNDM SSYS

Apr 13, 2026, 8:16 AM EDT - 5 weeks ago

Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies

2026-04-06T13:41:43.000Z - 6 weeks ago

Nano Dimension sells additively manufactured electronics product line to Inspira

NNDM

2026-04-06T13:16:43.000Z - 6 weeks ago

Inspira Technologies enters quantum computing sector

Apr 6, 2026, 9:01 AM EDT - 6 weeks ago

Inspira Enters Quantum Computing Sector, Targeting a Critical Connectivity Bottleneck with Newly Acquired AME Platform

Apr 6, 2026, 8:31 AM EDT - 6 weeks ago

Inspira Technologies Announces Acquisition of the AME Platform from Nano Dimension

2026-03-31T13:23:41.000Z - 6 weeks ago

Inspira Technologies announces termination of sales, equity purchase agreements

Mar 31, 2026, 8:16 AM EDT - 6 weeks ago

Inspira Technologies Terminates ATM and SEPA Equity Facilities to Prepare for Next Strategic Phase

Mar 26, 2026, 4:30 PM EDT - 7 weeks ago

Inspira Technologies Reports Full Year 2025 Financial Results and Provides Business Updates

2026-02-25T22:40:39.000Z - 2 months ago

Inspira receives Nasdaq minimum market value deficiency notice

Feb 25, 2026, 4:10 PM EST - 2 months ago

Inspira Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

2026-02-18T13:35:18.000Z - 3 months ago

Inspira announces deployment, initiation of evaluation of INSPIRA ART100

Feb 18, 2026, 8:32 AM EST - 3 months ago

Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State

2026-02-17T13:25:37.000Z - 3 months ago

Inspira Technologies announces strategic commercial showcase of Inspira ART100

Feb 17, 2026, 8:00 AM EST - 3 months ago

Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks

2026-02-12T21:56:06.000Z - 3 months ago

Inspira Technologies receives noncompliance notification from Nasdaq

Feb 12, 2026, 4:01 PM EST - 3 months ago

Inspira Technologies Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement

2026-02-09T12:20:52.000Z - 3 months ago

Inspira Technologies receives approval from Clalit for ART100 deployment

2026-02-05T13:15:57.000Z - 3 months ago

Inspira Technologies prices 6.79M shares at 70c in registered direct offering

2026-02-03T14:30:28.000Z - 3 months ago

Inspira Technologies announces validation of advanced blood labs of HYLA

Feb 3, 2026, 9:22 AM EST - 3 months ago

Inspira Technologies Validates Next-Gen Standalone HYLA™ Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market

2026-01-29T13:40:17.000Z - 3 months ago

Inspira Technologies announces Inspira ART100 system completed evaluation

Jan 21, 2026, 8:50 AM EST - 4 months ago

Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders

Jan 5, 2026, 10:46 AM EST - 4 months ago

CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation

Jan 5, 2026, 9:30 AM EST - 4 months ago

Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation

Dec 23, 2025, 8:30 AM EST - 5 months ago

Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones

Dec 15, 2025, 8:30 AM EST - 5 months ago

Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution

Dec 3, 2025, 8:43 AM EST - 5 months ago

Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology

Nov 13, 2025, 9:00 AM EST - 6 months ago

Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission

Nov 6, 2025, 9:10 AM EST - 6 months ago

Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion

Oct 22, 2025, 8:30 AM EDT - 7 months ago

Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira's Global Ecosystem

Oct 21, 2025, 9:05 AM EDT - 7 months ago

Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm

Oct 1, 2025, 8:00 AM EDT - 8 months ago

Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update

Sep 11, 2025, 9:30 AM EDT - 8 months ago

Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance

Aug 22, 2025, 8:45 AM EDT - 9 months ago

Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market

Aug 7, 2025, 9:44 AM EDT - 10 months ago

Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years

Jul 31, 2025, 9:15 AM EDT - 10 months ago

Inspira Activates U.S. Based Consulting Firm to Execute Transformational Initiatives

Jul 18, 2025, 8:10 AM EDT - 10 months ago

Inspira Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jul 10, 2025, 9:25 AM EDT - 11 months ago

Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100

Jul 7, 2025, 8:50 AM EDT - 11 months ago

Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework

Jul 2, 2025, 9:23 AM EDT - 11 months ago

Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase

Jun 11, 2025, 9:10 AM EDT - 1 year ago

Inspira's ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions

Jun 5, 2025, 11:15 AM EDT - 1 year ago

CORRECTION - Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

Jun 5, 2025, 9:15 AM EDT - 1 year ago

Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

May 29, 2025, 9:15 AM EDT - 1 year ago

Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System

May 7, 2025, 8:45 AM EDT - 1 year ago

INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Inspira Achieves above 99% Gas Exchange Efficiency in VORTX™ Technology In-Vivo Animal Testing

Apr 15, 2025, 9:15 AM EDT - 1 year ago

Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems

Mar 25, 2025, 8:30 AM EDT - 1 year ago

Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego

Mar 18, 2025, 1:17 PM EDT - 1 year ago

PESG Report: Inspira Technologies' AI-Powered Respiratory System Could Revolutionize Care for 20 Million Annual ICU Patients in Combined $25+ Billion Market

Mar 14, 2025, 7:00 AM EDT - 1 year ago

Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care

Mar 13, 2025, 4:30 PM EDT - 1 year ago

Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates